Lunch & Learn, October 6th, Salk Institute for Biological Studies: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

genOway presentation

Event
-
October 6, 2026

‍

Join us for a Lunch & Learn session focused on one of the most critical challenges in modern drug development: improving the predictive power and translatability of in vivo models.

‍

📅 Tuesday, October 6th, 2026

🕛 12:00 - 1:00 PM

📍Parker Room - Salk Institute for Biological Studies, San Diego, USA

‍

In this session, we will focus on:

  • Next-generation humanized mouse models engineered to more accurately recapitulate human physiology
  • How these models help improve translational relevance and predictive power in preclinical research

This informal lunchtime session will include:

  • Expert presentations
  • Interactive discussion and Q&A
  • Networking over lunch
    ‍

Spaces are limited, secure your place today by filling in the form below.

Lunch & Learn, October 6th, Salk Institute for Biological Studies: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

Get in touch

Let us know how we can help

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
18th annual PEGS Europe, Lisbon, Portugal, November 16-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tukuba, Japan, November 16-19, 2026
Conference
Event
-
Nov 2026
Read on
SITC meeting 2026, Phoenix, Arizona, November 4-8
Conference
genOway presentation
Event
-
Nov 2026
Read on
2nd T-Cell Engager for Autoimmune Disease Summit, Boston, October 27-29, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe